Tapan S - Search Results

1

Plasma apelin and ADMA Levels in patients with essential hypertension.

Sonmez A, Celebi G, Erdem G, Tapan S, Genc H, Tasci I, Ercin CN, Dogru T, Kilic S, Uckaya G, Yilmaz MI, Erbil MK, Kutlu M. Sonmez A, et al. Among authors: tapan s. Clin Exp Hypertens. 2010 May;32(3):179-83. doi: 10.3109/10641960903254505. Clin Exp Hypertens. 2010. PMID: 20504125

2

LDL-cholesterol lowering increases plasma apelin in isolated hypercholesterolemia.

Tasci I, Erdem G, Ozgur G, Tapan S, Dogru T, Genc H, Acikel C, Ozgurtas T, Sonmez A. Tasci I, et al. Among authors: tapan s. Atherosclerosis. 2009 May;204(1):222-8. doi: 10.1016/j.atherosclerosis.2008.08.030. Epub 2008 Sep 4. Atherosclerosis. 2009. PMID: 18845302 Clinical Trial.

3

Soluble CD40 ligand and soluble P-selectin levels in Gilbert's syndrome: a link to protection against atherosclerosis?

Tapan S, Dogru T, Tasci I, Ercin CN, Ozgurtas T, Erbil MK. Tapan S, et al. Clin Biochem. 2009 Jun;42(9):791-5. doi: 10.1016/j.clinbiochem.2009.02.005. Epub 2009 Feb 13. Clin Biochem. 2009. PMID: 19232335

4

Plasma apelin levels in subjects with nonalcoholic fatty liver disease.

Ercin CN, Dogru T, Tapan S, Kara M, Haymana C, Karadurmus N, Karslioglu Y, Acikel C. Ercin CN, et al. Among authors: tapan s. Metabolism. 2010 Jul;59(7):977-81. doi: 10.1016/j.metabol.2009.10.019. Epub 2009 Dec 31. Metabolism. 2010. PMID: 20045153

5

Chitotriosidase activity predicts endothelial dysfunction in type-2 diabetes mellitus.

Sonmez A, Haymana C, Tapan S, Safer U, Celebi G, Ozturk O, Genc H, Dogru T, Tasci I, Erdem G, Taslipinar A, Aydogdu A, Yilmaz MI, Kurt I, Kutlu M. Sonmez A, et al. Among authors: tapan s. Endocrine. 2010 Jun;37(3):455-9. doi: 10.1007/s12020-010-9334-4. Epub 2010 Apr 11. Endocrine. 2010. PMID: 20960168

6

Decreased plasma apelin levels in pubertal obese children.

Tapan S, Tascilar E, Abaci A, Sonmez A, Kilic S, Erbil MK, Ozcan O. Tapan S, et al. J Pediatr Endocrinol Metab. 2010 Oct;23(10):1039-46. doi: 10.1515/jpem.2010.165. J Pediatr Endocrinol Metab. 2010. PMID: 21158215

7

Soluble CD40 ligand, soluble P-selectin and von Willebrand factor levels in subjects with prediabetes: the impact of metabolic syndrome.

Genc H, Dogru T, Tapan S, Tasci I, Bozoglu E, Gok M, Aslan F, Celebi G, Erdem G, Avcu F, Ural AU, Sonmez A. Genc H, et al. Among authors: tapan s. Clin Biochem. 2012 Jan;45(1-2):92-5. doi: 10.1016/j.clinbiochem.2011.10.022. Epub 2011 Nov 7. Clin Biochem. 2012. PMID: 22100896

8

Lower plasma soluble TWEAK concentration in patients with newly diagnosed hypertension.

Karadurmus N, Tapan S, Cakar M, Naharci I, Celik T, Tasci I, Sayin S, Dogan T, Turker T, Erbil MK, Saglam K. Karadurmus N, et al. Among authors: tapan s. Clin Invest Med. 2012 Feb 1;35(1):E20-6. doi: 10.25011/cim.v35i1.16102. Clin Invest Med. 2012. PMID: 22309961

9

The relation of ADMA and apelin to endothelial dysfunction and angiogenesis in patients with type 2 diabetes mellitus.

Tasci I, Erdem G, Tapan S. Tasci I, et al. Among authors: tapan s. Diabetes Res Clin Pract. 2009 Nov;86(2):e37-8. doi: 10.1016/j.diabres.2009.08.006. Epub 2009 Sep 18. Diabetes Res Clin Pract. 2009. PMID: 19766342 No abstract available.

10

Relationship between hemoglobin and CD40 ligand in prediabetes.

Kutlu M, Sonmez A, Genc H, Erdem G, Tapan S, Celebi G, Haymana C, Taslipinar A, Uckaya G, Erbil MK. Kutlu M, et al. Among authors: tapan s. Clin Invest Med. 2009 Dec 1;32(6):E244. doi: 10.25011/cim.v32i6.10659. Clin Invest Med. 2009. PMID: 20003829

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

102 results

Search Page